Property talk:P3637

Documentation

European Medicines Agency product number
identifier issued by the European Medicines Agency for treatments approved in the European Union
Descriptionan identifier issued by the European Medicines Agency for treatments approved in the European Union
Associated itemEuropean Medicines Agency (Q130146)
Data typeExternal identifier
DomainMedicine, Chemistry, Biology, Veterinary Medicine (note: this should be moved to the property statements)
Allowed values
According to this template: EMEA/[A-Z]{1}/[A-Z]{1}/{d}{6}
According to statements in the property:
EMEA(\/[A-Z]){2}\/\d{6}
When possible, data should only be stored as statements
ExampleActraphane (Q29004375) → EMEA/H/C/000427
Insuman (Q29006003) → EMEA/H/C/000201
Sourcehttp://ema.europa.eu/
See alsoNational Drug Code (P3640)
Lists
Proposal discussionProposal discussion
Current uses
Total3,050
Main statement1,07335.2% of uses
Qualifier2<0.1% of uses
Reference1,97564.8% of uses
Search for values
[create Create a translatable help page (preferably in English) for this property to be included here]
Format “EMEA(\/[A-Z]){2}\/\d{6}: value must be formatted using this pattern (PCRE syntax). (Help)
List of violations of this constraint: Database reports/Constraint violations/P3637#Format, hourly updated report, SPARQL
Scope is as main value (Q54828448), as reference (Q54828450): the property must be used by specified way only (Help)
List of violations of this constraint: Database reports/Constraint violations/P3637#Scope, hourly updated report, SPARQL
Allowed entity types are Wikibase item (Q29934200): the property may only be used on a certain entity type (Help)
Exceptions are possible as rare values may exist. Exceptions can be specified using exception to constraint (P2303).
List of violations of this constraint: Database reports/Constraint violations/P3637#Entity types
Return to "P3637" page.